Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2715 - Crucial relationship of Neural Wiskott Aldrich syndrome protein(N-WASP) and Lysyl oxidase-like 2(LOXL2) in the promotion of pancreatic cancer metastasis


09 Sep 2017


Poster display session


HyungSun Kim


Annals of Oncology (2017) 28 (suppl_5): v209-v268. 10.1093/annonc/mdx369


H. Kim1, J.S. Park2

Author affiliations

  • 1 Department Of Surgery, Gangnam Severance Hospital, KS013 - Seoul/KR
  • 2 Department Of Surgery, Gangnam Severance Hospital, Seoul/KR


Abstract 2715


Pancreatic cancer is known to have aggressive malignancy and poor prognosis. N-WASP is part of the WASP family that regulate actin polymerization. FAK (Focal adhesion kinase) promotes N-WASP and epithelial mesenchymal transition(EMT) in cancer metastasis. Previous studies reported the overexpression of LOXL2 activates FAK and Snail and promotes distant metastasis in pancreatic cancer. However, there are few evidence of the relation between LOXL2 and N-WASP. In this study, we aimed to confirm the expression of N-WASP and relationship of N-WASP and LOXL2 in pancreatic cancer.


Between June 2002 and December 2012, 80 patients underwent curative resection for pancreatic cancer at Gangnam Severance Hospital, Korea. Pancreatic cancer cell lines MIA PaCa-2, PANC-1 were used for in vitro study. We purified the whole RNA and protein to perform the RT-PCR and Western blot. We performed Chromatin immunoprecipitation(ChIP) assay to probe the interaction between Snail and promoter of N-WASP. And we confirmed the motility and invasiveness of MIA PaCa-2 and PANC-1.


Among the 80 patients, 81.2% were positive for LOXL2. On univariate and multivariate analyses, poor differentiation and LOXL2 were identified as prognostic factors for DFS. High expression of LOXL2 and N-WASP were observed and correlated with the expression of mesenchymal markers (Snail, L1CAM, Vimentin). We generated stably LOXL2 silenced pancreatic cancer cell which exhibited significant changes of factors related to invasiveness and N-WASP expression. There were poorly expressions of N-WASP in Snail silencing of same cell lines. In ChIP assay, we obtained the results of the association of Snail proteins with promoter of N-WASP. Silencing of N-WASP decreased motility and invasiveness of MIA PaCa-2 and PANC-1 as determined from wound healing assay.


Our results demonstrated that N-WASP is a regulator of EMT in pancreatic cancer. By identifying of N-WASP expression promoted by Snail, LOXL2 and N-WASP have a powerful relationship for activating the promotion of EMT in pancreatic cancer metastasis. These findings suggest that N-WASP can be a target for the determining of distant metastasis in pancreatic cancer.

Clinical trial identification

Legal entity responsible for the study

Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Gangnam Severance Hospital, Yonsei University College of Medicine




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.